We investigated, using laser-Doppler flow me try, whether nitric oxide (NO)-and/or indomethacin (lND)-sensitive mechanisms mediate the elevations of re gional cerebral blood flow (rCBF) elicited by electrical stimulation of the rostral ventrolateral medulla (RVL) in the anesthetized spinalized rat. Stimulation of the RVL for 10 s caused increased rCBF in the frontal cortex by 31 % (n = 46), peaking at 22 s and persisting for up to 8 min. Intravenous L-nitro-�-arginine (NNA) dose depen dently and reversibly increased arterial pressure and re duced basal and evoked rCBF to 74 and 54% of the con trol, respectively (p < 0.05; n = 7). Superfused over the cortex, NNA dose dependently reduced only the evoked elevations of rCBF, to .�9% of the control (p < 0.05; n = 6). Intravenous IND decreased the basal rCBF dose de pendently and decreased the elevations evoked from the Electrical or chemical stimulation of the rostral ventrolateral medulla (RVL) increases regional ce rebral blood flow (rCBF) in rat cerebral cortex (Saeki et aI., 1989; Underwood et aI., 1992) without parallel changes in regional cerebral glucose utiliza tion (Underwood et aI., 1992). The mechanism by which the afferent neural signal is transduced into vasodilation is unknown. The fact that a brief stim ulus train can elevate rCBF for minutes (Saeki et Received January 19, 1993; final revision received September 23, 1993; accepted September 30, 1993. Address correspondence and reprint requests to Dr. E. V. 
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We investigated, using laser-Doppler flow me try, whether nitric oxide (NO)-and/or indomethacin (lND)-sensitive mechanisms mediate the elevations of re gional cerebral blood flow (rCBF) elicited by electrical stimulation of the rostral ventrolateral medulla (RVL) in the anesthetized spinalized rat. Stimulation of the RVL for 10 s caused increased rCBF in the frontal cortex by 31 % (n = 46), peaking at 22 s and persisting for up to 8 min. Intravenous L-nitro-�-arginine (NNA) dose depen dently and reversibly increased arterial pressure and re duced basal and evoked rCBF to 74 and 54% of the con trol, respectively (p < 0.05; n = 7). Superfused over the cortex, NNA dose dependently reduced only the evoked elevations of rCBF, to .�9% of the control (p < 0.05; n = 6). Intravenous IND decreased the basal rCBF dose de pendently and decreased the elevations evoked from the Electrical or chemical stimulation of the rostral ventrolateral medulla (RVL) increases regional ce rebral blood flow (rCBF) in rat cerebral cortex (Saeki et aI., 1989; Underwood et aI., 1992) without parallel changes in regional cerebral glucose utiliza tion (Underwood et aI., 1992) . The mechanism by which the afferent neural signal is transduced into vasodilation is unknown. The fact that a brief stim ulus train can elevate rCBF for minutes (Saeki et RVL by 38% (p < 0.05), but IND was without effect when superfused. Combined, the effects of intravenous NNA and IND summated, reducing rCBF by 70%. However, when NNA and IND were superfused together, the inhi bition of the evoked vasodilation was comparable to that elicited by NNA alone. We conclude that the elevation in reBF elicited from the RVL is partially mediated by (a) NO synthesized locally in the cortex in response to an afferent neural signal and (b) an IND-sensitive mecha nism, probably a product of cyclooxygenase, located in larger cerebral arteries, in response to a retrograde vas cular signal resulting from increased blood flow within the brain. Key Words: Nitric oxide-Prostanoids-Regional cerebral blood flow-Vasopressin-Ventrolateral me dulla.
aI., 1989; Golanov et aI., 1991) suggests that the vascular response may result from repetitive action of local neurons and/or release of diffusible media tors.
In the present study we investigated whether two classes of vasoactive molecules are potential candi dates. One, nitric oxide (NO), is continuously syn thesized from L-arginine in brain and cerebral ves sels by the action of the constitutive form of nitric oxide synthase (NOS) (Palmer et aI., 1988; Bredt et aI., 1990; Moncada et aI., 1991; Murphy et aI., 1991) . NO not only tonically dilates cerebral vessels (Kovach et aI., 1992) but also may participate in the vasodilation elicited by electrical stimulation of the cerebellar fastigial nucleus (ladecola, 1992) . The other consists of those products of arachidonic acid metabolism generated by the action of cyc;looxy genase. These are most prominently, but not exclu sively, prostaglandins that can be synthesized in the brain and/or its vasculature (Abdel-Halim et aI., 1978) . Some are potent cerebrovascular vasodila tors (Pickard et al., 1980) .
Specifically we compared the effects on the rest ing rCBF and the vasodilation elicited from the RVL of inhibition of NOS with L-nitro-NJ -arginine (NNA) (Dwyer et aI., 1991) and of cyclooxygenase with indomethacin (IND) (Abdel-Halim et aI., 1978; Busija and Leffler, 1991) . By administering the agents intravenously or by cortical superfusion, it was possible to assess their likely sites of action. We demonstrate that NO-and IND-sensitive mech anisms, probably products of cyclooxygenase activ ity, contribute synergistically to basal and evoked cerebrovascular vasodilation. However, the agents appear to be generated at different sites in the brain. Preliminary results have been presented in an ab stract (Golanov et aI., 1991) .
MATERIALS AND METHODS

General procedures
Studies were performed with 50 male Sprague-Dawley rats weighing 300-380 g. They were anesthetized with 5% isoflurane in 100% O2 so as to avoid the hypoxia resulting from atelectasis common in the anesthetized rat (Nathan and Reis, 1975) . The hyperoxia does not modify rCBF (Heistad et ai. , 1983) . Isoflurane was reduced to 2% dur ing surgery and to 1. 5% during the remainder of the ex periment.
Polyethylene catheters were placed in femoral arteries to record the arterial pressure (AP) and to sample blood gases and in femoral veins for continuous administration of phenylephrine by infusion pump (Harvard Apparatus Model 940) to maintain the AP after spinal cord transec tion (see below) and for intermittent administration of drugs. The trachea was cannulated. The wounds were closed and the rats paralyzed with ( + )-tubocurarine (0. 5 mg/kg i. m.) and ventilated (Rodent Respirator, Harvard Apparatus). Body temperature was maintained at 37 ± OSC with a heating lamp thermostatically controlled by a rectal probe (YSI Model 73A). Arterial Pac02, Pa02, and pH were measured in 0. 1 ml of arterial blood with a blood gas analyzer (Ciba Corning M:ode1 178 pH/Blood Gas An alyzer). Blood gases did not vary among experimental groups (Table 1) .
Animals were placed in a stereotaxic frame (Kopt) with the bite bar adjusted to -11 mm. The dorsal surface of the skull, occipital bone, and atlantoatlas juncture were exposed. For monopolar recording of the electroenceph alogram (EEG), a stainless-steel screw was inserted into the right parietal bone 2 mm lateral to the midline and 2 mm caudal to the bregma and placed upon the dura. The indifferent electrode was a clip placed on the masseter muscle. EEG activity was displayed on a chart recorder throughout the experiment to monitor cerebral cortical viability. Spreading depression was never observed.
For placement of the laser-Doppler flowmetry (LDF) probe, a hole 2-2. 5 mm in diameter (or 3-4 mm for ex periments with cortical superfusion), was drilled over the frontal cortex, with the center 1.5-2 mm lateral to the midline and 1. 5 mm rostral to the bregma. The drill was irrigated with cool saline to prevent overheating of the underlying cortex. A portion of the occipital bone was removed for placement of stimulating electrodes in the medulla.
Spinal cord transection was made at the level of the first cervical segment (C1) and the wound packed with Gelfoam. Immediately preceding transection, 0. 1 ml of 2% procaine was injected into the lesion site to abolish the associated transient elevation of AP and an infusion of phenylephrine begun so as to counteract the resulting fall in AP. Completeness of the transection was verified post mortem.
Monitoring of rCBF by LDF rCBF was continuously monitored by LDF (Nilsson, 1990 ) using a PeriFlux PF3 (Perimed) flowmeter, with flow values expressed as arbitrary units (perfusion units). The analog output was fed into an A/D converter and continuously displayed on the chart recorder. Changes in rCBF are expressed as percentage change in flow. The probe (Model PF303; tip diameter, 1.0 mm) was mounted on a micromanipulator (Kopt) and inserted through the frontal burr hole over the cortex (see above). The under lying cortex was examined under magnification to define a recording site devoid of arterioles or venules, since re cordings from these larger vessels may give erroneous results (Iadecola and Reis, 1990) . For quick assessment of the proper probe placement and cortical viability, cere brovascular reactivity was assessed at the beginning and at various times during the study by stopping the venti lator for 20 s. This procedure increased the P aco2 to 63 ± 9 mm Hg (range, 51-75 mm Hg) without producing hyp oxia (Pao2 decreased to 125 ± 23 mm Hg) and elevated rCBF by 50--60% promptly and reversibly, with full re covery in 50--60 s. If CO2 reactivity was lost during the course of an experiment, it was discontinued. Once a suitable placement was obtained, the probe was fixed in place for the remainder of the study, with precautions taken to obtain optimal recording conditions and avoid signal artifacts (Bonner and Nossal, 1990; Iadecola and Reis, 1990) .
Electrical and chemical stimulation
The medulla was electrically stimulated through mono polar electrodes fabricated from Teflon-coated stainless steel wires (l50-/Lm o. d.), with only the cut surface ex posed. Cathodal square-wave pulses of 0. 5-ms duration, 70--90 /LA, and 50 Hz were generated in lO-s trains and passed through a constant-current stimulus isolation unit (Grass Model PSIU6). The anode was a metal clip at tached to the scalp. Stimulation sites were histologically verified postmortem (see below).
Agents were microinjected into the medulla through glass pipettes (40 to 60-/Lm tips). The site in the RVL found to be most responsive to mapping with electrical stimulation was chosen as the site for microinjection. All drugs were dissolved in phosphate-buffered saline at a pH of 7. 4 ± 0.03. The injection volume was 20--40 nl, deliv ered by positive pressure over 20--30 s. The pipette was left in place for at least 3 min following each injection to minimize backflow up the pipette tract. Pipette tracks were localized postmortem (see below).
Cortical superfusion
The frontal cortex was superfused while recording rCBF. Under magnification, the dura in the skull hole (see above) was opened and a specially designed probe was positioned over the cortex. The probe consisted of a LDF probe to which three polyethylene tubes (o.d. , 0. 56 mm) and a thermoprobe were attached with silicone based glue. Two of the tubes were used to deliver the superfusing solutions and the third served as outflow. The underlying cortex was continuously superfused through one inflow tube with a peristaltic pump (300 /Ll/min). The solution was saturated with 5% CO2-95% 02 and warmed with a water jacket to maintain the temperature of the superfusate at 37.0--37 .2°C. The composition of the per fusate was (mM) 119 NaCl, 4. 6 KCl, 1. 5 CaCI2, 1. 2 MgCI2, 15 NaHC03, 1. 2 NaH2P0 4 , and 11 glucose. At the outflow, the superfusate had a pH of 7.42 ± 0.17, a Pco2 of 28. 9 ± 2. 0 mm Hg, and a P02 of 122. 4 ± 3. 9 mm Hg. Drugs were applied through the second inflow tube.
Experimental protocol
Brain stimulation. After anesthetization, cannulation, exposure of the caudal brain stem, and placement of the LDF probe, an electrode mounted on a micromanipulator with a 10° posterior inclination was positioned on the ca lamus scriptorius and the stereotaxic coordinates were recorded as stereotaxic zero. The electrode was then moved to a site 1 mm rostral, 1. 9 mm lateral, and 1. 5 mm ventral to stereotactic zero.
The spinal cord was then transected and the AP main tained between 90 and 110 mm Hg by continuous infusion of phenylephrine (1.3-6.4 /Lg/min) (Table 1), as described above. Neither spinal cord transection (if AP and blood gases were maintained) nor continuous infusion of phen ylephrine (lade cola and ) affected the resting rCBF.
J Cereb Blood Flow Metab, Vol, 14, No, 3, 1994 Approximately 30 min after the completion of spinal cord transection, when AP and blood gases were at steady state, the most active RVL site was localized. The electrode was lowered in 0.2-mm steps and, at each step, stimulated with a current intensity of 20--30 /LA. An active site in the RVL was defined as one at which stimulation resulted in an elevation in rCBF ;;.10% of baseline. Once the active site was localized, the electrode was left in place for the remainder of the study. For systemic (intravenous) administration, agents were dissolved in saline and the pH was adjusted to 7.4 ± 0.02. NNA and IND were dissolved in warm (40°C) 2% sodium bicarbonate and the pH was subsequently adjusted with hydrochloric acid to 7.4. AVP and DPAVP were dis solved in saline and small portions of stock solution were frozen. They were thawed and diluted to appropriate con centrations at the time of the experiment.
For dose/response studies, NNA or IND was adminis tered cumulatively: Each dose was delivered 7-8 min af ter the previous dose and the R VL stimulated 2-5 min after the injection. That this timing was suitable was es tablished in pilot experiments in which we observed, in agreement with observations of others (Wang and Pang, 1990; Kozniewska et ai., 1992) , that a steady-state eleva tion of AP was achieved within 2 min of intravenous ad ministration of a bolus of NNA or stabilization of rCBF after systemic administration of IND. In the case of IND, the timing is in agreement with the pharmacodynamics of the agent, with IND achieving a constant bloodlbrain dis tribution ratio in rats in 2 min (Hucker et ai., 1966) . All drug solutions were injected in a volume of 1 ml/kg body weight.
In superfusion studies, drug solutions were prepared at two times the final concentrations in warm Ringer's so lution or saline. After adjustment of pH, they were coper fused with an equal volume of vehicle. Combined, artifi cial cerebrospinal fluid and Ringer's solution did not af fect rCBF (data not shown). Drugs were applied at each dose for 12-15 min: 5 min before and 7-10 min after RVL stimulation and before changing to the next higher dose. Thus, with four doses of NNA and IND tested, the over all time of superfusion of the drugs was over 60 min.
Datum collection and analysis
Mean AP was derived from pulsatile arterial pressure by high-frequency filtering and heart rate (HR) computed by a tachograph (Grass Model 7P4F). For estimation of cerebrovascular resistance (CVR) changes, we calculated the ratio of AP change (percentage) to rCBF change (per centage). After amplification and filtering (Grass 7D Poly graph), all physiological data (i. e., rCBF, AP, HR) were digitized on-line using an AD board (Lab Master DMA, Scientific Solutions) and stored by computer for subse quent analysis. Simultaneously, an analog signal was re corded on channels of the chart recorder.
Each trial of RVL stimulation was controlled automat ically and lasted 6 min, during which all parameters (ex cluding EEG) were collected continuously. At th� begin ning of the second minute, a stimulator (Grass S8800B) was activated to deliver a lO-s stimulus train to the RVL. The onset of response was defined as the point when the amplitude of the parameter changed by more than two standard deviations from the baseline. Baseline was de fined as the average of data from the first minute of the trial.
Localization of electrode tracks and histology
At the end of each experiment, a small electrolytic le sion was made by passage of a DC current through the stimulating electrode (100 J-lA for 20 s). In mapping ex periments, lesions (50 J-lA for 20 s) were made at two points 1-2 mm apart along an electrode track. Animals were then perfused with 4% buffered formalin through the left cardiac ventricle and the brains saved for histology. In some experiments, to avoid shrinkage, brains were removed immediately after the experiment and frozen in Freon ( -25°C). Brains were sectioned at 20 J-lm in a cryo stat in such a way that the plane of section coincided with the plane of the electrode or cannula track. Sections were stained with thionine. The locations of electrode or pi pette sites were reconstructed using a camera lucida.
Statistics
Data are expressed as mean ± SD. For comparisons of the effects of different doses of the agents, one-way anal ysis of variance with the least-significant difference test was used. Differences were considered significant at p < 0.05.
RESULTS
Effect of RVL stimulation on rCBF
By systematically mapping the medulla with fixed stimuli (20 j.LA in 10 rats), we observed that active sites were concentrated within the ventral medulla ( Fig. O . but also seen within regions of the lateral tegmental field lying between the nucleus of the sol itary tract and the ventral medulla, i.e., the bed nucleus of the transtegmental tract (Reis and Rug giero, 1990) , in and around the spinal trigeminal nu cleus and the nucleus of the VIIth nerve. The most potent sites were congregated in the ventral medulla 1.0 mm rostral to the calamus scriptorius, in an area corresponding to the most caudal aspect of the RVL (Ruggiero et al., 1989) , which was the stimulation site used for the remainder of the study, referred to hereafter as the RVL.
Elevations of rCBF elicited from the R VL were graded with respect to stimulus frequency and in tensity, with optimal parameters comparable to those reported by Underwood et al. (1992) . The op timal stimulus frequency was 50 Hz, and the thresh old current between 10 and 20 j.LA, with the re sponse increasing linearly as the current was in creased to reach a maximum (at 50 Hz) near 50 j.LA. Microinjection into this site of L-glutamate (L-Glu) (5 nM in 20 nl) or kainic acid (KA) (5 nM in 20 n1) increased rCBF by 14.8 ± 8.4% (p < 0.05; n = 5) and 94.5 ± 14.1% (p < 0.001; n = 3), respectively, indicating that the effect on rCBF is attributable to excitation of local neurons (Underwood et al., 1992) . Electrical stimulation of the RVL in spinal- ized rats elicited a short-latency elevation of rCBF and decreased CVR by 16 ± 4% (p < 0.05). After reaching the maximum, rCBF gradually returned to the baseline in the following 7-8 min (Figs. 2 and 3 , Table 2 ).
Associated with the elevation in rCBF was a small and delayed elevation of AP, which, at max imum, averaged 18%. The elevation in AP appeared later than the elevation in rCBF and persisted for almost 6.5 min ( Table 2 ). The delayed elevation in AP elicited in the spinalized rat appears to result from the recognized (Ross et al., 1984) release of A VP, which does not significantly affect rCBF, since (a) administration of A VP in a dose sufficient to produce a comparable elevation in AP did not significantly change rCBF (Table 3) (Table 3) ; and (c) DPAVP alone had no effects on rCBF (data not shown). Therefore, AVP, while responsible for the delayed pressor response, does not contribute to the associated elevations in rCBF elicited from the RVL.
Effects of systemic or local administration of NNA
Intravenous NNA (n = 7) dose dependently in creased the AP. The threshold dose was 10 mg/kg and maximum elevations, approximately 48%, were obtained at a cumulative dose of 60 mg/kg (Fig. 4A) . L-Arg (400 mg/kg i.v.) rapidly reduced, but did not entirely reverse, the hypertension (Fig. 4A) , while D-Arg (400 mg/kg i.v.) had no effect (data not shown).
NNA, also dose dependently, reduced the basal rCBF (up to 27%; Fig. 4A ) and increased the CVR (by 120 ± 20%; p < 0.05). The threshold and max imal doses of NNA required to change the rCBF (60 and 100 mg/kg, respectively) were substantially higher than those that elevated the AP. L-Arg par tially restored the rCBF (Fig. 4A) , while D-Arg was without effect. Intravenous NNA significantly reduced the ele vation in rCBF evoked by stimulation of the RVL (Fig. 4B) . The threshold dose, 10 mg/kg, was similar to that which, by itself, elevated the AP but less than the dose required to reduce the basal rCBF. The maximal reduction in the evoked vasodilation, approximately 50% (to 13.5 ± 9.2 from 32.3 ± 10.2% before injection, p < 0.05), was obtained at 60 mg/kg (Fig. 4B) . At this dose CVR was reduced from 13 ± 3 to 9 ± 5% (p < 0.05). The inhibition of the evoked response was reversed by L-Arg (400 mg/kg i.v.), but not D-Arg.
In contrast to its systemic effects, superfusion of the cerebral cortex with NNA (n = 6) did not affect the AP, basal rCBF, or CVR (Fig. 5A) . However, the evoked vasodilation was significantly and dose dependently reduced. The maximum reduction, ap proximately 61 % (to 10.0 ± 9.9 from 26.0 ± 5.9%; p < 0.05) occurred at the highest dose, I mg/ml ( 5B). At this dose CVR decreased from 15 ± 4 to 7 ± 4% (p < 0.05). L-but not O-Arg (4 mg/ml each) partially restored the response (Fig. 5B) . These ob servations indicate that it is NO generated locally within the cerebral cortex that contributes to the vasodilation evoked from the RVL.
Effects of INO
Intravenous IND (n = 8) dose dependently re duced the basal rCBF and increased the CVR by 54 ± 17% (p < 0.05), without affecting the AP. The maximum reduction, approximately 25%, was ob tained at 30 mg/kg (Fig. 6A) . INO also dose depen dently reduced the elevation in rCBF (Fig. 6B ) and fall in CVR (from 17 ± 3 to 9 ± 3%; p < 0.05) anesthetized spinalized rats (mean ± SD) evoked from the RVL. The maximum inhibition of the elevation in rCBF, approximately 38% (from 32.9 ± 5.1 to 20.7 ± 17.2%;p < 0.05), was obtained at a dose of 10 mg/kg. Superfusion of the cerebral cortex with cumula tive doses of INO, from 0.25 to 5 mg/ml, (n = 4) had no effect on the AP or on the basal or evoked rCBF (Fig. 7) .
Combined effects of NNA and IND
To investigate the synergism of NNA-and IND sensitive mechanisms (Katzenschlager et aI., 199 1) in regulating the evoked vasodilation elicited from the RVL, NNA and INO were administered in sep arate groups of animals by serially injecting vehicle, NNA at the threshold dose for reduction of the evoked response (1 0 mg/kg i.v.), and IND at the threshold for reduction of the baseline rCBF (1 0 mg/kg). NN A was administered before IND in three rats, and the reverse sequence was used in three others. Since the results were similar, the data were pooled.
In these rats NNA alone increased the AP (Fig. 8 ) and reduced the evoked elevation of rCBF by 30% (Fig. 6 ) but did not alter the basal rCBF. IND alone reduced only the evoked elevation of the rCBF re sponse, by 30% (corresponding to the effect of the drug administered alone). Combined, NNA and INO inhibited the evoked vasodilation by 70% (from 29.8 ± 4.5 to 8.4 ± 2.9%) and reduced the fall in CVR from 11 ± 3 to 7 ± 3% (p < 0.05). This response represents a summation of the effects of each drug given separately (Fig. 8) . Superfusion of the cortex with NNA (1 mg/ml) combined with IND (5 mg/ml) in three rats did not change the basal rCBF but suppressed the evoked elevation in rCBF by approximately 53% (to 14.7 ± 2.1 from 25.7 ± 2.6%; p < 0.05) (Fig. 9 ) and decreased the fall in CVR from 12 ± 4 to 5 ± 3%. These responses are comparable to those elicited by NNA alone (Fig. 5) .
In summary, the results demonstrate that NNA and IND administered systemically summate to re duce the elevations of rCBF evoked from the RVL, without having additive actions on the baseline Cumulative dose (mg/kg) of NNA Cumulative dose (mg/kg) of NNA rCBF. However, when superfused together, the ef fects are no different from those produced by NN A alone.
DISCUSSION
In the present study, we observed that electrical and chemical stimulation of the R VL in spinalized rat elicits, by excitation of local neurons, a pro longed elevation of rCBF in the frontal cortex. These findings confirm and extend the observations of Saeki et al. (1989) and Underwood et aI. (1992) but are in partial disagreement with the observa tions of Maeda et aI. (1991) . The elevation in rCBF elicited from the RVL by a lO-s stimulus train in spinalized animals has a gradual onset and persists for 7-8 min after its termination. The prolonged time course of the cerebrovascular response cannot result from spinalization since it occurs in intact animals (Saeki et aI., 1989) and, as we have dem-A. Basal to the effect of NNA. n = 7. onstrated here, cannot be attributed to release of AVP evoked by stimulation of the RVL (Ross et aI., 1984) .
To ascertain the contribution of NO to the cere brovascular vasodilation elicited from the RVL, we investigated the effects of inhibiting its biosynthetic enzyme, NO S, with NNA administered intrave nously or by cortical superfusion. In agreement with others (Wang and Pang, 1990; Gardiner et aI., 1991; Zambetis et aI., 1991) , we observed that NNA elicited a dose-dependent increase in AP and also reduced the basal rCBF (Arneric et aI., 1991; Gotoh et aI., 1991; Tanaka et aI., 1991; Kovach et aI., 1992) . However, we also found that the evoked vas cular response elicited from the RVL was reduced by 50% when NNA was administered intravenously and by 61% when it was superfused over the cere bral cortex in doses which did not change the basal rCBF or AP. The local actions of NNA appear to be specifically related to inhibition of NOS since they were partially reversed by superfused L-but not D-Arg. However, about 40% of the evoked vasodi lation persisted after maximal doses of NNA, indi cating that a substantial component of the response is NO independent. The failure of NNA, when ap plied topically, to modify the resting flow has been noted by others (Iadecola, 1992) . This indicates that NO contributes little, if anything, to background vasodilation in cortical arterioles, at least when the extracellular pH is stable (Niwa et aI., 1993) , in con trast to its more substantial actions on larger cere bral arteries (Marshall and Kontos, 1992) . The source of NO that contributes to the vasodi lation evoked from the RVL is not certain. Consti tutive NOS is expressed in neurons, cerebral vas cular endothelium, some perivascular nerves (Bredt et aI., 199 0) , and astrocytes (Wallace and Fredens, 1992) and, with the exception of perivascular nerves, would be activated by afferent neuronal ac tivity.
We investigated the effects of IND on the re sponse. In agreement with others (see Pickard et aI., 1980; Dahlgren et aI., 1981) , we observed that IND, administered intravenously, dose dependently reduced the basal rCBF without changing the AP. IND also reduced the vasodilation elicited from the RVL, by 35%, over a dose range comparable to that for its effects on basal flow. Unlike NNA, how ever, IND was without effect when superfused over the cortex for up to 60 min.
While the failure of superfused IND to influence the evoked change in rCBF might reflect failure of the agent to reach its biological target, this seems unlikely. IND rapidly penetrates brain (Hucker et aI., 1966) and reduces the content of prostaglandins in the central nervous system and cerebrospinal fluid after subcutaneous, intravenous, or intracere broventricular administration (Abdel-Halim et aI., 1978; Busija and Leffler; Saperas et aI., 199 1) , and the dosages used here are well above those demonstrated to inhibit synthesis of brain pros taglandins maximally ex vivo (Kunievsky et aI., 1990) . Rather, the results suggest that the site of IND action is located proximal to the intracortical microvessels, probably within major afferent cere bral arteries and/or arterioles.
IN D is a potent inhibitor of cyclooxygenase (Pickard et aI., 1980) and, as such, will block the generation of prostanoids, e.g., prostaglandin 12, which is known to be tonically generated in blood vessels and is a potent vasodilator in the rat brain (Abdel-Halim et aI., 1980; White and Hagen, 1982) . Inhibition of cyclooxygenase also may increase the availability of arachidonic acid to lipoxygenase or decrease the production of free radicals (Siesj6 and NNA +IND Wieloch, 1983) . However, the lipoxygenase path way does not mediate the cerebrovascular effects of IND (Bouchi et aI., 1985) , and cerebral vascular tone is affected predominantly by the prostanoids produced from arachidonic acid but not free radi cals (Leffler et aI., 1985) . There is still the pos sibility that IND can affect rCBF through non prostaglandin-mediated mechanisms (Siesj6 and Wieloch, 1983; Wang et aI., 1993), e.g., acting as an inhibitor of AMP-dependent protein kinase (Kantor and Hampton, 1978) or a calcium antagonist (Northover, 1977) . The present study, therefore, suggests that the prolonged increase in rCBF elicited in the cerebral cortex by briefly exciting intrinsic neurons in the RVL (Reis and ladecola, 1989) is partly, but not entirely, mediated by both NNA-and IND sensitive mechanisms. However, each of these mechanisms appears to be active in different com partments. NNA-sensitive NO production by NOS is localized within, or in close apposition to, cortical microvessels since the response to RVL stimulation is inhibited equally by NNA applied locally or sys temically. In contrast, the IND-sensitive mecha nism is localized proximally within larger (feeder) cerebral arteries. Afferent arteries dilating in re sponse to retrograde signals (shear stress due to increased flow velocity) generated in the target in other vascular beds is a well-recognized mechanism for maintaining a constant flow diameter relation in afferent arteries to meet increased demand (Pohl et aI., 1986; Bassenge and Miinzel, 1988) .
